PB 76 of 2013
National Health (Listed drugs on F1 or F2) Amendment Determination 2013 (No. 7)
National Health Act 1953
I, FELICITY MCNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.
Dated 26 November 2013
FELICITY MCNEILL
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health
Part 1 Preliminary
1 Name of Determination
(1) This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2013 (No. 7).
(2) This Determination may also be cited as PB 76 of 2013.
2 Commencement
This Determination commences on 1 December 2013.
3 Amendment of National Health (Listed drugs on F1 or F2) Determination 2010
Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).
Schedule 1 Amendments
(Section 3)
[1] Schedule 1, after item dealing with Albendazole
Insert
Alogliptin
[2] Schedule 1, after item dealing with Calcium
Insert
Canagliflozin
[3] Schedule 1, after item dealing with Dabigatran etexilate
Insert
Dabrafenib
[4] Schedule 1, after item dealing with Dantrolene
Insert
Dapagliflozin
[5] Schedule 1, after item dealing with Didanosine
Insert
Dimethyl fumarate
[6] Schedule 1, after item dealing with itraconazole
Insert
Ivabradine
[7] Schedule 1, after item dealing with Rifampicin
Insert
Rifaximin
[8] Schedule 1, after item dealing with Terbutaline
Insert
Teriflunomide
[9] Schedule 1, after item dealing with Zidovudine
Omit
Ziprasidone
[10] Schedule 2, after item dealing with Vinorelbine
Insert
Ziprasidone